Literature DB >> 33055138

Carotid Disease and Retinal Optical Coherence Tomography Angiography Parameters in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.

Jocelyn J Drinkwater1, Fred K Chen2,3,4, Alison M Brooks1, Brad T Davis5, Angus W Turner2, Timothy M E Davis6, Wendy A Davis1.   

Abstract

OBJECTIVE: To use optical coherence tomography angiography (OCTA) to determine whether retinal microvascular parameters are associated with carotid arterial disease in people with type 2 diabetes. RESEARCH DESIGN AND METHODS: Participants (community-based) underwent detailed assessments including carotid ultrasonography and OCTA. Ultrasound images were assessed for mean intima-media thickness (IMT) and the presence of stenosis. OCTA image analysis provided measures of vessel density, foveal avascular zone (FAZ) area, blood flow areas, and retinal thickness. For each OCTA variable, the most parsimonious model was generated using generalized estimating equations, then ipsilateral and contralateral carotid disease-related variables were added to determine their significance.
RESULTS: A total of 474 eyes from 261 participants (mean ± SD age 72.0 ± 9.3 years, 57.1% males, median diabetes duration 15.4 years [interquartile range 11.1-22.4]) were analyzed. When carotid variables were added to the most parsimonious models, the ipsilateral natural logarithm of common carotid artery IMT (coefficient -2.56 [95% CI -4.76, -0.35], P = 0.023) and presence of any ipsilateral stenosis (-0.82 [-1.48, -0.17], P = 0.014) were statistically significantly associated with a lower parafoveal density in the deep capillary plexus. A mean bifurcation IMT ≥1 mm was associated with a decreased vessel density in the 300-μm ring surrounding the FAZ (coefficient -0.79 [-1.50, -0.08], P = 0.030)). Contralateral carotid disease-related variables were also significantly associated with retinal microvascular parameters.
CONCLUSIONS: This is the first study to show that carotid disease is an independent associate of retinal microvascular disease assessed by OCTA in type 2 diabetes. Appropriately intensive management of carotid disease may improve the retinal microcirculation.
© 2020 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2020        PMID: 33055138     DOI: 10.2337/dc20-0370

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  3 in total

Review 1.  Cardiovascular Risk Stratification in Diabetic Retinopathy via Atherosclerotic Pathway in COVID-19/Non-COVID-19 Frameworks Using Artificial Intelligence Paradigm: A Narrative Review.

Authors:  Smiksha Munjral; Mahesh Maindarkar; Puneet Ahluwalia; Anudeep Puvvula; Ankush Jamthikar; Tanay Jujaray; Neha Suri; Sudip Paul; Rajesh Pathak; Luca Saba; Renoh Johnson Chalakkal; Suneet Gupta; Gavino Faa; Inder M Singh; Paramjit S Chadha; Monika Turk; Amer M Johri; Narendra N Khanna; Klaudija Viskovic; Sophie Mavrogeni; John R Laird; Gyan Pareek; Martin Miner; David W Sobel; Antonella Balestrieri; Petros P Sfikakis; George Tsoulfas; Athanasios Protogerou; Durga Prasanna Misra; Vikas Agarwal; George D Kitas; Raghu Kolluri; Jagjit Teji; Mustafa Al-Maini; Surinder K Dhanjil; Meyypan Sockalingam; Ajit Saxena; Aditya Sharma; Vijay Rathore; Mostafa Fatemi; Azra Alizad; Vijay Viswanathan; Padukode R Krishnan; Tomaz Omerzu; Subbaram Naidu; Andrew Nicolaides; Mostafa M Fouda; Jasjit S Suri
Journal:  Diagnostics (Basel)       Date:  2022-05-14

2.  Novel Findings of Retinal and Choroidal Features Utilizing Optical Coherence Tomography Angiography Analysis in Patients With Autoimmune Posterior Uveitis.

Authors:  Junhui Shen; Jinfeng Kong; Si Chen; Xin Liu; Yan Teng; Hailan Wu; Lijuan Wang; Manman Wu; Zhaoan Su; Lei Feng
Journal:  Front Med (Lausanne)       Date:  2022-01-11

3.  Associations Between the Macular Microvasculatures and Subclinical Atherosclerosis in Patients With Type 2 Diabetes: An Optical Coherence Tomography Angiography Study.

Authors:  Jooyoung Yoon; Hyo Joo Kang; Joo Yong Lee; June-Gone Kim; Young Hee Yoon; Chang Hee Jung; Yoon Jeon Kim
Journal:  Front Med (Lausanne)       Date:  2022-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.